Assessment of Safety, Pharmacokinetics and Efficacy in a Combination Treatment With SMP-114

NCT00296257 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

312

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis (RA)

Interventions

DRUG: SMP-114

Sponsor

Dainippon Sumitomo Pharma Europe LTd.